EPIGET 50MG

Epiget 50mg injection contains Epirubicin Hydrochloride as its active ingredient. This antineoplastic medication is classified under anthracyclines. It is utilized as adjuvant therapy alongside other drugs to treat breast cancer in patients who have undergone tumor removal surgery. Additionally, it is effective in treating cancers of the breast, ovaries, stomach, bowel, and lung. Furthermore, this medication is also employed in the treatment of cancers affecting blood-forming tissues, including malignant lymphomas, leukemias, and multiple myeloma.

Do not administer this injection if you are allergic to Epirubicin or any of its components, if you are pregnant or breastfeeding, or if you have severe liver and bladder issues. Prior to starting treatment, it is essential to inform your healthcare provider about any kidney or liver conditions, recent vaccinations, or any acute toxicities such as mouth inflammation, low white blood cell or platelet counts, or infections. This medication may elevate your risk of developing blood clots.

This medication has the potential to cause infertility in both men and women; therefore, it is important to notify your doctor if you are planning to conceive. If you are sexually active, it is recommended to use effective contraception to avoid pregnancy. Your physician will conduct regular laboratory tests to monitor the effects of this medication. Common side effects associated with Epiget 50mg injection include decreased white blood cells, low platelet counts, irregular menstrual cycles, fatigue, nausea or vomiting, diarrhea, eye infections, skin rashes, or itching.